| Presentations from the Meeting |
|
Monday, December 08, 2008
PL1 - Present and Future in Cardiovascular Interventions
Opening Ceremony
The Future of PCI
Innovation in CardioVascular Business
Case Transmission - Aortic Valve Replacement
Operators: Haim Danenberg (Israel), Jean-Claude Laborde (France) PARALLEL SESSIONS S1-S4
S1 - Transcatheter Aortic Valve Replacement
Case Transmission - Aortic Valve Replacement Cont.
Candidates for Percutaneous Aortic Valve Implantation
Transcatheter Aortic Valves
Procedural and 30-day outcomes following Transcatheter Aortic Valve Implantation Using the Third Generation (18F) CoreValve Revalving® System
PANEL DISCUSSION: S2 - Drug-Eluting and Bare Metal Stents: Old and New Solutions
Chairs: Ran Kornowski, Israel
Drug-Eluting Stent Management Issues
Meta-Analysis of Spirit II&III @ Two-Year
A Comparative Analysis of Major Clinical Outcomes Using Drug-Eluting Stents vs. Bare Metal Stents in a Large Single Center Israeli Clinical Setting
Bioabsorbable Stents
INDUSTRY VIEW:
Next Generation Sirolimus Eluting Stents: Enhancing Outcomes through Innovation
5 Years Follow Up of Titanox Coated Stent in Bern S3 - Non Coronary Vascular Interventions and Innovations
Chairs: Gabriel Bartal, Israel
Endovascular AAA Repair with Unfavorable Proximal Necks
Efficacy and Durability of CAS: A Single High Volume Center Report
Carotid Stenting - Current State of the Art
Endovascular Management of Intracranial Stenose
Role of the AngioSculpt Scoring Balloon for the Treatment of Critical Limb Ischemia: Final Results From the Belgian Registry
A Novel Ultrasound Based Catheter System for the Creation of Arterio-Venous Anastamosis in the Lower Limb
Population Screening for Abdominal Aortic Aneurysm - The Time Has Come
S4 - Back to the Future: Cell Therapy for Heart Disease
Scientific Background and Rationale of Cell Therapy for Heart Disease
The Human Heart Contains Cardiomyocyte Progenitor Cells
Cell Therapy for Post-infarction Heart Failure and Ventricular Arrhythmias
Directing Adult Stem Cells into Cardiomyocytes
Cardiac Cell Repair Therapy - Current Status
PANEL DISCUSSION:
PARALLEL SESSIONS LC1-LC4
LC1 - Interventions and Innovations in Thrombus Containing Lesions
The Role of Thrombectomy and Protective Devices in Coronary Interventions
Revisiting Thrombus Extraction in Primary Percutaneous Coronary Intervention
Protection against Embolization during PCI-ACS; PIHARTE Trial and MGuard New Data
Optimal Management of High Thrombus Burden in Infarct Related Vessels
The Challenges in Embolic Protection
PANEL DISCUSSION:
LC2 - CT Imaging and Beyond
Cardiac CT Today and Tomorrow
Coronary CT Angiography in Asymptomatic Diabetics
Novel Method for Real time Hybrid Cardiac CT and Coronary Angiography Image Registration - Visualizing beyond Lumenology
Integrated SPECT/CT for the Assessment of Hemodynamically Significant Coronary Artery Lesions
Magnetic Resonance Coronary Angiography: State of the Art
PANEL DISCUSSION: LC3 - Regeneration and Repair by Tissue Engineering and Vasculogenesis. Where Are We Now?
Chairs: Alexander Battler, Israel
HLA-Matched Engineered Heart Muscle for Myocardial Repair Applications
Engineering Vascularized Cardiac Muscle Tissue
In Situ Tissue Engineering - from Bench to Bedside
Therapeutic Angiogenesis - from Bench to Bedside
Endothelial Progenitor Cells for Diagnosis and Treatment
PANEL DISCUSSION:
LC4 - Current and Future Surgical Solutions for Organic Heart Disease
New and Future Surgical Solutions for the Failing Heart
Hybrid Approach to AF- Early Clinical Results
Ventor Embracer- A Surgical Aortic Valve Bioprosthesis for Transapical Implantation
Surgical Endoscopic Mitral Valve Repair
PANEL DISCUSSION:
PARALLEL SESSIONS S5-S8
Chairs: Shmuel Einav, Israel
Endovascular Polymer Systems: Stents, Paving and Tissue Engineering
Medtronic Emerging Technologies - Innovation through Collaboration
Resident Stent Cells in the LAA
TVP1022 a Novel Cardioprotective Drug, for the treatment of Acute Coronary Syndrome (ACS) and Congestive Heart Failure (CHF)
Reverse Remodeling after Myocardial Infarction with Intracoronary Injection of BioLineRx's BL-1040 Myocardial Implant
Extracorporeal Myocardial Revascularization Therapy (ESMR) to Induce Local Angiogenesis to Myocardial Ischemic Areas Using Low Intensity Focused Shockwaves.
S6 - BMS - DES and Beyond
New DES
Titanium-Nitride-Oxide Coated Stents Versus Paclitaxel-Eluting Stents in Acute Myocardial Infarction: A 24-Months Follow-Up Report from the TITAX AMI Trial
Biomatrix, New Generation DES with Biodegradable Polymer Compared to First Generation DES, Cypher Select. The Leaders Trial 12 Months Results
SPIRIT V
Drug Eluting Balloon SeQuent® Please Results of the PEPCAD Clinical Program
Long Term Safety & Efficacy Profile of the Endeavor DES Clinical Program
Silicon Carbide Coating on Cobalt Chromium Stents Leads to Early Differentiating Functional Endothelial Layer, Increased Safety and DES-like Recurrent Stenosis Rates
12-Month Results from the ATLANTA FIM with a New Class of Stent: the CATANIA™ Coronary Stent with Polyzene®-F
The Drive for Innovations - The Scientist, the Physician and the Entrepreneur
Medical Device Start-up (Israel & US Synergy)
A Clinical View on the Role of Developments in Medicine: New Imaging Frontiers to Improve Clinical Outcomes
Risk of Rapture in Abdominal Aortic Aneurysms and Vulnerable Plaques: A Patient Based Fluid Structure Interaction Approach
Biosensors Innovative DES Technology: From Biodegradable to Polymer Free
PANEL DISCUSSION:
S8 - Acute MI Interventions 2008
Acute MI - What is New in An Old Disease ?
The Timing of Reperfusion Therapy
Acute MI Interventions
No-reflow in Acute MI
Stent Thrombosis. Case Closed?
The Clinical Impact of FFR During Coronary Intervention
Pro-Healing Stents in Patients with Acute Myocardial Infarction
Reperfusion Injury and Microvascular Dysfunction: The Dark Side of Reperfusion
PANEL DISCUSSION
PARALLEL SESSIONS S9-S10
Thinking Global: Current Challenges with Medical Device Startups
Novel Fully Bioabsorbable Salicylate-Based Sirolimus-Eluting Stent
Simplifying Bifurcation Interventions with the Antares™ Stent System
The MGuard™ - Net Protective Stent
The CiTop™ for Recanalization of Peripheral and Coronary Chronic Total Occlusions (CTO)
Non-Carrier DES
Pericardial Covered Stent for SVG Lesion
Proactive Prevention of Stroke From Emboli A New Frontier
S10 - TECHNOLOGY PARADE (Ischemia, Imaging and Devices for Heart Failure)
Comparison of the Sensitivity Implantable and Surface Impedance Devices for Prediction the Evolution of Acute Heart Failure
An Innovative Non-Invasive Respiratory Stress Test Indicates Significant Coronary Artery Disease
The Arineta Cardiac Dedicated CT System
Efficacy Assessment of a New Device-based Approach for Treating Diastolic Heart Failure
The CorPathTM Vascular Robotics System
CardiOp-THV - Angiography-Based System for Trans-Catheter Heart Valve Procedure Planning and Real-Time Positioning
A Novel Vascular Booster Device for Critical Limb Ischemia : Feasibility and Safety Studies
Chronic Vagus Nerve Stimulation – A New Target for Treatment of Congestive Heart Failure
Simulation Dry Run of Carotid Stenting Using the Simbionix PROcedure Rehearsal Studio
PARALLEL SESSIONS S11-S14
S11 - Device Innovations in Health Care: From Bench to Bedside
Starting an Innovation Program - A Cardiologist View
New CV Technology – A View from Silicon Valley
Co-operation between the Industry and the Medical Community
Sourcing Global Technical Innovation
Bioabsorbable Sirolimus-Loaded Nanoarticles For Targeted Angioplasty Drug Delivery (TADD)
Pathway Medical Solutions to Peripheral Interventions
PANEL DISCUSSION:
S12 - Interventions and Innovations for Complex PCI
Unprotected Left Main Stenting
Left Main Coronary Artery Stenting: Rational and Technique
A 100% Bioresorbabble Polymer Stent: 1 & 3 Month Results in the Rabbit Iliac Artery
The Treatment of Bifurcation Lesions: The Importance of the Angulation
Is There a Role for Bifurcation Dedicated Stents?
Role of a Scoring Balloon in the Treatment of Coronary Bifurcation Lesions: Preliminary Results from the U.S. Multi-Center Trial – AGILITY PRESENTATIONS OF BEST POSTERS:
First in Man 3 Month OCT Follow-up on a New DES with a Biodegradable Polymer
First in Man One Year Clinical Outcomes of the CATANIA™ Coronary Stent System with NanoThin Polyzene®-F in De Novo Native Coronary Artery Lesions: Assessment of the LAtest Non-Thrombogenic Angiop
Cappella Sideguard Self-Expanding Sidebranch Stent: First-in-Man Clinical and Angiographic Outcomes in Patients with Bifurcation Coronary Lesions
PANEL DISCUSSION:
S13 - Clinical Aspects of Interventions and Case Studies
Percutaneous Interventions for Acute Vein Graft Occlusion
New Treatment Options for Refractory Angina Patients
TAPED VIDEO CASES:
Treatment of Acute MI with Large Thrombotic Mass
Plaque Shift at the Site of LCP as Detected by LipiScan : An Observation From the Spectacl Study
No Balloon Deflation Inviting Complication
Endovascular Treatment of Iatrogenic Aortic Dissection
Intracoronary infusion of tPA during PCI to origin of LAD
S14 - Transcather Therapeutics in Structural Heart Disease
Transcatheter Therapeutics in Structural Heart Disease
Trans-Catheter Device-Specific ASDs / PFOs Closure – Critical Appraisal of Available Armament and Recommended Therapeutic Strategies
Transcatheter Closure of Large Coronary Fistulae, Pulmonary Fistulae – Review of Techniques and Devices
Left Atrial Appendage Closure: An Alterative Treatment to Anticoagulation in A-Fib Patients
Trans Catheter Pulmonic Valve Replacement – The Melody Experience
Post MI VSD, Considerations for the Interventionalist
PANEL DISCUSSION:
PL2 - Innovations that Will Change Our Interventions
The Engines for Innovations
What Will Be the Impact of the Syntax Study on the European Practice ICI ACHIEVEMENT AWARD SPONSORS' AWARD
Case Transmission - Transapical Aortic Valve Replacement PARALLEL SESSIONS LC5-LC8
LC5 - Interventional Cardiology - Beyond the Heart
THE CLINICAL BENEFIT OF RENAL STENTING: FACT OR FICTION?
The Clinical Benefit of Renal Stenting -Fiction Discussion, Q & A
A Hybrid Approach for Using DES / BMS
Extended Utilization of the PRO-Kinetic Stent – Single Center and other Experiences
LC6 - CTO Club: 2008 Experience
The Treatment of Chronic Total Occlusions in Contemporary Practice
Technical Aspects of CTO Intervention
Basic Research and Animal Models in CTO Recanalization
First-in-Man Results with the Ovalum CiTop™ ExPander™ Guidewire in Chronic Total Occlusions
Novel Devices and Strategies for CTO Recanalization
PANEL DISCUSSION:
LC7 - Cardiovascular Innovations: Regulatory and Ethical Aspects
Cutting Time to Market for New Products
FDA Initiatives and Global Device Evaluation
Israel is a Nest for Cardio Innovations
The FDA Regulatory Process: Protecting Patient Safety and Balancing Risks and Benefits in a Least Burdensome Manner
PANEL DISCUSSION:
LC8 - Mitral Valve Repair
Coronary Sinus and Percutanoeus Coronary Sinus Annuloplasty – Percutaneous Mitral Valve Repair
Edge to Edge Repair and the Everest Trail
Mitralign’s FIM Mitral Valve CorrectionIndustry Valve Corrections
Advances in Mitral Valve Repair-Surgeons' View
Simple Percutaneous Treatment for Functional Mitral Regurgitation: Acute and Six Month Impact of the CARILLON Mitral Contour System in the AMADEUS Study
Minimally Invasive Mitral Repair Combined with AF Ablation
PANEL DISCUSSION: PARALLEL SESSIONS S15-S18
S15 - The Vulnerable Plaque: From Imaging to Clinical Practice
Imaging of the Vulnerable Plaque
Optical Coherence Tomography to Detect the Vulnerable Plaque
Intravascular MRI for Vulnerable Plaque Detection
Invasive Imaging for Vulnerable Plaque – PROSPECT Trial Results
Two Years Follow Up of the ABSORB - A Multi-Imaging Modality Approach
Identification of Lipid-rich Plaques in Coronary Arteries with NIR Spectroscopy
PANEL DISCUSSION:
S16 - Heart Failure and Cardiac Support Devices: Present and Future Directions
Heart Failure: A Difficult Target for Device Therapy , Clinical and Regulatory Considerations
Monitoring of Heart Failure Patients by Device Based Technologies
Cardiac Support, Temporary and Permanent, A New Concept
Myocardial Revovery: New Frontier in the Treatment of Heart Failure
INDUSTRY VIEW:
The Coherex FlatStent PFO Closure Device
PANEL DISCUSSION:
S17 - Adjunctive Medical Therapy
Cessation of Clopidogrel after PCI
Obligate Drug-device Safety Interaction: A Global Response to the Challenge of Defining "Optimal" Dual Antiplatelet Therapy and DES
Gastro-intestinal Bleeding after Percutaneous Coronary Intervention: A Dreadful Combination
Plavix Non-responders: How to Treat
Prognostic Value of Adjunct Pharmacotherapy in PCI
Obstacles to Anti-Platelet Treatment in Patients Following PCI: Significant Interactions between Aspirin/Plavix and Other Medications
PANEL DISCUSSION:
S18 - Navigation and Simulations
Robotic Catheter Intervention: The Hansen Sensei System
Intracoronary Navigation and Tip Positioning Using the MediGuide gMPS Enabled GMC System
Virtual Rehearsal with Patient-Specific Simulation
Navigation Stereotaxis System
Vascular Robotics for Coronary intervention: The CorPath™ System
PANEL DISCUSSION: |
